Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 167-176 , June 2006

Diagnosis of hyperandrogenism: clinical criteria

  • Bulent O. Yildiz, MD (Associate Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +90 312 305 1707.

References 

  1. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. The Journal of Clinical Endocrinology and Metabolism. 2004;89(2):453–462
  2. Carmina E, Rosato F, Janni A, et al. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. The Journal of Clinical Endocrinology and Metabolism. 2006;91(1):2–6
  3. Ehrmann DA. Polycystic ovary syndrome. The New England Journal of Medicine. 2005;352(12):1223–1236
  4. Rittmaster RS. Hirsutism. Lancet. 1997;349(9046):191–195
  5. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocrine Reviews. 2000;21(4):347–362
  6. Carmina E, Koyama T, Chang L, et al. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?. American Journal of Obstetrics and Gynecology. 1992;167(6):1807–1812
  7. McKnight E. The prevalence of ‘hirsutism’ in young women. Lancet. 1964;41:410–413
  8. Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. The Journal of Clinical Endocrinology and Metabolism. 1998;83(9):3078–3082
  9. O'Driscoll JB, Mamtora H, Higginson J, et al. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clinical Endocrinology. 1994;41(2):231–236
  10. Sonino N, Fava GA, Mani E, et al. Quality of life of hirsute women. Postgraduate Medical Journal. 1993;69(809):186–189
  11. Mercurio MG, Gogstetter DS. Androgen physiology and the cutaneous pilosebaceous unit. The Journal of Gender-Specific Medicine. 2000;3(4):59–64
  12. Ewing JA, Rouse BA. Hirsutism, race and testosterone levels: comparison of east Asians and Euroamericans. Human Biology. 1978;50(2):209–215
  13. Uno H. Quantitative models for the study of hair growth in vivo. Annals of the New York Academy of Sciences. 1991;642:107–124
  14. Randall VA. Androgens and human hair growth. Clinical Endocrinology. 1994;40(4):439–457
  15. Wendelin DS, Pope DN, Mallory SB. Hypertrichosis. Journal of the American Academy of Dermatology. 2003;48(2):161–179[quiz 180–1]
  16. Trueb RM. Causes and management of hypertrichosis. American Journal of Clinical Dermatology. 2002;3(9):617–627
  17. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. The Journal of Clinical Endocrinology and Metabolism. 1961;21:1440–1447
  18. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology. 1981;140(7):815–830
  19. Harper JC. An update on the pathogenesis and management of acne vulgaris. Journal of the American Academy of Dermatology. 2004;51(supplement 1):S36–S38
  20. Thomas DR. Psychosocial effects of acne. Journal of Cutaneous Medicine and Surgery. 2004;8(supplement 4):3–5
  21. Shaw JC. Acne: effect of hormones on pathogenesis and management. American Journal of Clinical Dermatology. 2002;3(8):571–578
  22. Pochi PE, Strauss JS. Sebaceous gland response in man to the administration of testosterone, delta-4-androstenedione, and dehydroisoandrosterone. The Journal of Investigative Dermatology. 1969;52(1):32–36
  23. Stewart ME, Downing DT, Cook JS, et al. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Archives of Dermatological. 1992;128(10):1345–1348
  24. Marynick SP, Chakmakjian ZH, McCaffree DL, Herndon JH. Androgen excess in cystic acne. The New England Journal of Medicine. 1983;308(17):981–986
  25. Borgia F, Cannavo S, Guarneri F, et al. Correlation between endocrinological parameters and acne severity in adult women. Acta Dermato-Venereologica. 2004;84(3):201–204
  26. Imperato-McGinley J, Gautier T, Cai LQ, et al. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. The Journal of Clinical Endocrinology and Metabolism. 1993;76(2):524–528
  27. Oberemok SS, Shalita AR. Acne vulgaris, I: pathogenesis and diagnosis. Cutis. 2002;70(2):101–105
  28. Witkowski JA, Parish LC. The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clinical Dermatology. 2004;22(5):394–397
  29. Pochi PE, Shalita AR, Strauss JS, et al. Report of the consensus conference on acne classification, Washington, D.C., March 24 and 25, 1990. Journal of the American Academy of Dermatology. 1991;24(3):495–500
  30. Slayden SM, Moran C, Sams WM, et al. Hyperandrogenemia in patients presenting with acne. Fertility and Sterility. 2001;75(5):889–892
  31. Kuhn BH. Male pattern alopecia and/or androgenic hirsutism in females. 3. Definition and etiology. Journal of the American Medical Women's Association. 1972;27(7):357–364
  32. Girman CJ, Hartmaier S, Roberts J, et al. Patient-perceived importance of negative effects of androgenetic alopecia in women. Journal of Women's Health and Gender-Based Medicine. 1999;8(8):1091–1095
  33. Sawaya ME. Clinical updates in hair. Dermatologic Clinics. 1997;15(1):37–43
  34. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. The British Journal of Dermatology. 1977;97(3):247–254
  35. Rebora A. Pathogenesis of androgenetic alopecia. Journal of the American Academy of Dermatology. 2004;50(5):777–779
  36. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for androgenetic alopecia. American academy of dermatology. Journal of the American Academy of Dermatology. 1996;35(3 Pt 1):465–469
  37. Futterweit W, Dunaif A, Yeh HC, Kingsley P. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. Journal of the American Academy of Dermatology. 1988;19(5 Pt 1):831–836
  38. Cela E, Robertson C, Rush K, et al. Prevalence of polycystic ovaries in women with androgenic alopecia. European Journal of Endocrinology. 2003;149(5):439–442
  39. Marshburn PB, Carr BR. Hirsutism and virilization. A systematic approach to benign and potentially serious causes. Postgraduate Medicine. 1995;97(1):105–106
  40. Tagatz GE, Kopher RA, Nagel TC, Okagaki T. The clitoral index: a bioassay of androgenic stimulation. Obstetrics and Gynecology. 1979;54(5):562–564
  41. Fraser IS, Kovacs G. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Practice and Research Clinical Obstetrics and Gynaecology. 2004;18(5):813–823

PII: S1521-690X(06)00021-2

doi: 10.1016/j.beem.2006.02.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 167-176 , June 2006

Article Tools

* Image Usage & Resolution